Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byValeant Pharmaceuticals International
Price$318M
Date5/2010

General Information

Websiteatonrx.com
CategoryBioTech
Phone609-671-9010
Employees
Founded2001

Offices

Lawrenceville, USA
3150 Brunswick Pike
Suite 230
Lawrenceville, NJ, 08648
USA

People

Tags

Aton Pharma

Aton Pharma, Inc. operates as a specialty pharmaceutical company. It focuses on ophthalmic diseases, orphan conditions, and acute care hospital products. The company offers products for metabolic, neurological, and cardiovascular diseases, as well as provides products for under-treated diseases, including dry eye. Its products include timolol maleate ophthalmic gel forming solution for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. The company serves patients, caregivers, and healthcare professionals in the United States, the Asia Pacific region, Australia, and internationally. Aton Pharma, Inc. was formerly known as Avatar. The company was founded in 2001 and is based in Lawrenceville, New Jersey. Aton Pharma, Inc. is a former subsidiary of Merck & Co., Inc.

Recent Milestones

Videos

Screenshots

Aton Pharma screenshot
Above: Home Page
Uploaded: 5/6/10

Sources

  1. Valeant to buy orphan drug developer Aton for $318M (fiercebiotech.com) [edit]
Edit This Page
Last Edited 12/19/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy